MINIMUM SAMPLE-SIZE ESTIMATION TO DETECT GENE ENVIRONMENT INTERACTION IN CASE-CONTROL DESIGNS

被引:102
作者
HWANG, SJ
BEATY, TH
LIANG, KY
CORESH, J
KHOURY, MJ
机构
[1] JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT BIOSTAT, BALTIMORE, MD 21205 USA
[2] CTR DIS CONTROL & PREVENT, DIV BIRTH DEFECTS & DEV DISABIL, ATLANTA, GA 30341 USA
关键词
CASE-CONTROL STUDIES; ENVIRONMENT; GENETIC MARKERS; RESEARCH DESIGN;
D O I
10.1093/oxfordjournals.aje.a117193
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
As genetic markers become more available, case-control studies will be increasingly important in defining the role of genetic factors in disease causality. The authors estimate the minimum sample size needed to assure adequate statistical power to detect gene-environment interaction. One assumption is made: the prevalence of exposure is independent of marker genotypes among controls. Given the assumption, six parameters (three odds ratios, the prevalence of exposure, the proportion of those with the susceptible genotype, and the ratio of controls to cases) dictate the expected cell sizes in a 2 x 2 x 2 table contrasting genetic susceptibility, exposure, and disease. The three odds ratios reflect the association between disease and I) exposure among non-susceptibles; 2) susceptible genotypes among nonexposed individuals; and 3) the gene-environment interaction itself, respectively. Given these parameters, the number of cases and controls needed to assure any particular Type I and Type II error rates can be estimated. Results presented here demonstrate that case-control designs can be used to detect gene-environment interaction when there is both a common exposure and a highly polymorphic marker of susceptibility.
引用
收藏
页码:1029 / 1037
页数:9
相关论文
共 14 条
[1]  
ARDINGER HH, 1989, AM J HUM GENET, V45, P348
[2]   RELEVANCE OF METABOLIC POLYMORPHISMS TO HUMAN CARCINOGENESIS - EVALUATION OF EPIDEMIOLOGIC EVIDENCE [J].
CAPORASO, N ;
LANDI, MT ;
VINEIS, P .
PHARMACOGENETICS, 1991, 1 (01) :4-19
[3]  
CHENEVIXTRENCH G, 1991, AM J HUM GENET, V48, P1012
[4]   GENETICALLY-DETERMINED DIFFERENCES IN DRUG-METABOLISM AS A RISK FACTOR IN DRUG TOXICITY [J].
EICHELBAUM, M ;
KROEMER, HK ;
MIKUS, G .
TOXICOLOGY LETTERS, 1992, 64-5 :115-122
[5]  
GREENBERG DA, 1993, AM J HUM GENET, V52, P135
[6]   ASSOCIATION BETWEEN POLYMORPHISM OF THE GLYCOGEN-SYNTHASE GENE AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
GROOP, LC ;
KANKURI, M ;
SCHALINJANTTI, C ;
EKSTRAND, A ;
NIKULAIJAS, P ;
WIDEN, E ;
KUISMANEN, E ;
ERIKSSON, J ;
FRANSSILAKALLUNKI, A ;
SALORANTA, C ;
KOSKIMIES, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (01) :10-14
[7]  
HODGE SE, 1993, AM J HUM GENET, V53, P367
[8]   THE EFFECT OF GENETIC SUSCEPTIBILITY ON CAUSAL INFERENCE IN EPIDEMIOLOGIC STUDIES [J].
KHOURY, MJ ;
STEWART, W ;
BEATY, TH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (04) :561-567
[9]   ASSOCIATION BETWEEN ALLELES OF THE TRANSFORMING GROWTH FACTOR-ALPHA LOCUS AND THE OCCURRENCE OF CLEFT-LIP [J].
SASSANI, R ;
BARTLETT, SP ;
FENG, HS ;
GOLDNERSAUVE, A ;
HAQ, AK ;
BUETOW, KH ;
GASSER, DL .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1993, 45 (05) :565-569
[10]  
Schlesselman J., 1982, CASE CONTROL STUDIES